SNES Key Statistics, Chart & Performance
The current stock price of SNES is 2.27 USD. In the past month the price decreased by -23.29%. In the past year, price decreased by -29.56%.
SNES Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 47.82 | 994.07B | ||
| JNJ | JOHNSON & JOHNSON | 19.78 | 494.59B | ||
| MRK | MERCK & CO. INC. | 12.38 | 270.64B | ||
| PFE | PFIZER INC | 8 | 145.53B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.28 | 110.63B | ||
| ZTS | ZOETIS INC | 20.44 | 57.11B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.81 | 23.27B | ||
| VTRS | VIATRIS INC | 5.41 | 14.51B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.54 | 11.70B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.67B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.60B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 4.30B |
Related stock screener links
About SNES
Company Profile
SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Phoenix, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Company Info
SENESTECH INC
777 W. Pinnacle Peak Road, Suite B104
Phoenix ARIZONA 85027 US
CEO: Kenneth Siegel
Employees: 23
Phone: 19287794143
SENESTECH INC / SNES FAQ
What does SNES do?
SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Phoenix, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
What is the stock price of SENESTECH INC today?
The current stock price of SNES is 2.27 USD. The price increased by 1.34% in the last trading session.
What is the dividend status of SENESTECH INC?
SNES does not pay a dividend.
How is the ChartMill rating for SENESTECH INC?
SNES has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists SNES stock?
SNES stock is listed on the Nasdaq exchange.
Is SENESTECH INC (SNES) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SNES.
Can you provide the short interest for SNES stock?
The outstanding short interest for SENESTECH INC (SNES) is 0.79% of its float.
SNES Technical Analysis
SNES Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SNES. The financial health of SNES is average, but there are quite some concerns on its profitability.
SNES Financial Highlights
Over the last trailing twelve months SNES reported a non-GAAP Earnings per Share(EPS) of -9.97. The EPS increased by 96.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -39.89% | ||
| ROE | -51.41% | ||
| Debt/Equity | 0.01 |
SNES Forecast & Estimates
7 analysts have analysed SNES and the average price target is 10.2 USD. This implies a price increase of 349.34% is expected in the next year compared to the current price of 2.27.
For the next year, analysts expect an EPS growth of 72.07% and a revenue growth 24.9% for SNES